Why Deutsche Bank Still Isn’t Convinced About Intuitive Surgical (ISRG)

With a short percentage of shares outstanding of 2.05%, Intuitive Surgical, Inc. (NASDAQ:ISRG) is among the 7 Best Longevity and Anti-Aging Stocks to Buy.

On June 2, Deutsche Bank reduced its price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) to $366 from $440 while maintaining a Sell rating on the shares. The revised target reflects the firm’s updated valuation outlook for the company, although the adjustment did not alter its broader investment stance on the stock.

On May 28, Intuitive Surgical, Inc. (NASDAQ:ISRG) announced the promotion of Taylor Patton to the role of chief commercial and marketing officer, effective July 1. Patton, who most recently served as global senior vice president of the company’s endoluminal business, will become a member of the executive leadership team and succeed Henry Charlton, who is transitioning to the position of senior vice president of global business operations. Having spent nearly two decades with Intuitive Surgical, Patton has held a variety of leadership roles across commercial operations, marketing, and clinical application engineering, bringing extensive institutional knowledge and industry experience to his new position.

Founded in 1995 and headquartered in Sunnyvale, California, Intuitive Surgical, Inc. (NASDAQ:ISRG) produces robotic-assisted, minimally invasive surgery via its flagship da Vinci systems. Its primary involvement focuses on health span by providing less traumatic, more precise surgical options with quicker recovery times, enhancing how well people live as they age.

READ NEXT: 10 Most Overvalued Quantum Computing Stocks According to Short Sellers and 7 Best Pet Care Stocks to Buy for Consistent Recurring Revenue.

Disclosure: None.  Follow Insider Monkey on Google News.